About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 42,097 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,097 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7101-7120 of 42,097 trials

CompletedVisual Outcomes of Subjects Bilaterally Implanted With ReSTOR Aspheric +4 vs. Tecnis or Acri.LISAThis is a study to compare visual outcomes of subjects bilaterally implanted w/ReSTOR to subjects bilaterally implanted with the Tecnis Multifocal Intraocular Lens (IOL) or…NCT00721253·Fort Worth, Texas CompletedGleevec Study for Patients With Ovarian CancerPrimary Objectives: 1.NCT00510653·Houston, Texas CompletedRadiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)The Philips Angio-iFR medical software device is intended to provide information on the functional significance of a coronary artery lesion to provide guidance on diagnostic…NCT03857503·Long Beach, California and 39 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

RecruitingStudy to Evaluate the Safety and Efficacy of Ublituximab in Participants With SchizophreniaThe main objective of this Phase 2 study is to assess the efficacy of ublituximab as measured by Positive and Negative Syndrome Scale (PANSS) total score in participants with…NCT07680946·Little Rock, Arkansas and 1 other

CompletedComparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 DiabetesThis trial is conducted in Europe, Africa and the United States of America (USA).NCT00537303·Fresno, California and 68 others

RecruitingProton or Photon RT for Retroperitoneal SarcomasThis research study is a Phase I clinical trial. Phase I clinical trials test the safety of an investigational intervention.NCT01659203·Chicago, Illinois and 9 others

CompletedA Study of Cebranopadol for the Treatment of Acute Pain After BunionectomyThe purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a bunionectomy.NCT06423703·Sheffield, Alabama and 9 others

CompletedPazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau SyndromeThis phase II trial studies the side effects and how well pazopanib hydrochloride works in treating patients with von Hippel-Lindau syndrome.NCT01436227·Houston, Texas

CompletedChemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's DiseaseRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00002827·Long Beach, California and 38 others

RecruitingRegorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]To learn about the effects of the drugs regorafenib and lorigerlimab on circulating tumor DNA (ctDNA) in patients with CRC and who have radiographic occult minimal residual…NCT07071961·Houston, Texas

CompletedStudy to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )This study determines the Annualized Relapse Rate (ARR) in participants with RMS after 96 weeks (approximately 2 years) treatment with intravenous (IV) infusion of…NCT03277261·Carlsbad, California and 13 others

RecruitingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER StudyThis phase III trial compares the effect of decreased number of radiation (ultra-hypofractionated) treatments to the usual radiation number of treatments (hypofractionation) with…NCT07097142·Fort Smith, Arkansas and 210 others

TerminatedTagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaThis phase Ib/II trial studies the effects of tagraxofusp and low-intensity chemotherapy in treating patients with CD123 positive acute lymphoblastic leukemia or lymphoblastic…NCT05032183·Houston, Texas

CompletedOcriplasmin Research to Better Inform Treatment (ORBIT)This is a multicenter, prospective, observational, Phase 4 study that will assess clinical outcomes and safety of JETREA® administered in a real-world setting for the treatment of…NCT02079883·Phoenix, Arizona and 109 others

CompletedIdalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilTo establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).NCT02006641·Phoenix, Arizona and 161 others

TerminatedStudy to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.A phase 1, open-label, dose escalation and expansion study of PF-07062119 in patients with selected advanced or metastatic gastrointestinal tumorsNCT04171141·Duarte, California and 18 others

CompletedNonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of…NCT04411641·Birmingham, Alabama and 305 others

CompletedEvaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102This research study involves an investigational product: Ad-RTS-hIL-12 given with veledimex for production of human IL-12.NCT03679754·Los Angeles, California and 3 others

CompletedEffect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet ObstructionThe primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have…NCT00147654·Birmingham, Alabama and 94 others

RecruitingStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)This is a Phase 1/2, open-label, non-randomized, 4-part trial to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D)…NCT04198766·Duarte, California and 41 others

PreviousPage 356 of 2105Next

Heart Diseasein Texas